Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Within-subject Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLIFT® XC Versus Control for the Correction of Moderate to Severe Nasolabial Folds

NCT01976663 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01976663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01976663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Within-subject Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLIFT® XC Versus Control for the Correction of Moderate to Severe Nasolabial Folds
Lead sponsor
Allergan
Phase
Not applicable
Overall status
Completed
Start date
October 29, 2013
Completion date
October 26, 2015
Enrollment
126 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe nasolabial folds